5A14 | Human CDK2 with type II inhibitor | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Alexander, L.T., Elkins, J.M., Kopec, J., Fedorov, O., Savitsky, P.A., Moebitz, H., Cowan-Jacob, S.W., Szklarz, M., Pike, A.C.W., Carpenter, E.P., Krojer, T., Bountra, C., Edwards, A.M., Knapp, S. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.00 | ||||||||||||
ligand | ACE, LQ5 | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Type II Inhibitors Targeting CDK2., Alexander LT, Mobitz H, Drueckes P, Savitsky P, Fedorov O, Elkins JM, Deane CM, Cowan-Jacob SW, Knapp S, ACS Chem Biol. 2015 Sep 18;10(9):2116-25. doi: 10.1021/acschembio.5b00398. Epub, 2015 Jul 20. PMID:26158339 |
Data retrieval |
View 5A14 in 3D |
Visual 3D analysis of 5A14 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5A14 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |